Commentary

Use baby formula to check for bladder integrity


 

References

Dr. Gebhart responds
Dr. Raymond, I thank you for your comments and question. I applaud your surgical skill set and approach to hysterectomy. My preferred route of hysterectomy for benign disease is the vaginal route. A few years ago we published an article in OBG Management on keys to success in vaginal hysterectomy.1 Indeed, the vaginal approach remains the least expensive and least morbid approach to hysterectomy, yet the least common. I continue to publish and lecture on the benefits of a vaginal approach and societies, such as the Society of Gynecologic Surgeons (SGS), remain committed to teaching and advocating this well-established, evidence-based yet underutilized approach.

Given the interest and controversy in the use of power morcellation after the FDA’s Safety Communication last April,2 it was felt that a good technical review of abdominal hysterectomy was cogent. If surgeons have a concern about using power morcellation or their institution has banned use of a power morcellator, then the abdominal route is the most likely alternative for removing the enlarged uterus intact. As you state, the abdominal approach remains the most common route of hysterectomy. My sense is that most providers faced with an enlarged uterus that cannot be removed via laparoscopic morcellation (for reasons stated previously) are likely to turn to abdominal hysterectomy. Hopefully, the article gives readers a chance to assess and develop their technical approach to abdominal hysterectomy.

References

  1. Occhino JA, Gebhart JB. The difficult vaginal hysterectomy: 5 keys to success. OBG Manag. 2010;22(11):32–47.
  2. US Food and Drug Administration. Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA Safety Communication. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm393576.htm. Published April 17, 2014. Accessed December 8, 2014.

Share your thoughts on these letters or on another article! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Pages

Recommended Reading

Nitrous oxide for labor pain
MDedge ObGyn
Does this new evidence for noninvasive prenatal testing to detect fetal aneuploidy move NIPT closer to universal use in pregnancy?
MDedge ObGyn
Uterus ruptures at home: My most memorable experience of a transferred home birth
MDedge ObGyn
FDA issues new pregnancy/lactation drug label standards
MDedge ObGyn
CDC seeks comment on draft circumcision guidance
MDedge ObGyn
Consider biopsy for active lupus nephritis in pregnancy
MDedge ObGyn
Watchful waiting is viable option for unruptured ectopic pregnancies
MDedge ObGyn
Nearly 9% of Medicaid-financed births are early elective deliveries
MDedge ObGyn
Evaluating the impact of FDA’s pregnancy and lactation labeling rule
MDedge ObGyn
Preeclampsia in SLE ups CVD risk
MDedge ObGyn

Related Articles